Table 2.
All (n = 920) | Years 1–4 (n = 301) | Years 5–9 (n = 619) | P value | |
---|---|---|---|---|
Any complication | 86 (9.3) | 23 (7.6) | 63 (10.2) | 0.230 |
Major complication | 43 (4.7) | 9 (3.0) | 34 (5.5) | 0.098 |
Major adverse cardiovascular events | 23 (2.5) | 4 (1.3) | 19 (3.1) | 0.175 |
In-hospital death | 3 (0.3) | 1 (0.3) | 2 (0.3) | 1.0 |
Stroke | 2 (0.2) | 1 (0.3) | 1 (0.2) | 0.548 |
Periprocedural MI | 18 (2.0) | 2 (0.7) | 16 (2.6) | 0.072 |
| ||||
Coronary complications | 37 (4.0) | 13 (4.3) | 24 (3.9) | 0.724 |
CTO vessel | 27 (2.9) | 10 (3.3) | 17 (2.7) | 0.678 |
Donor vessel | 10 (1.1) | 3 (1.0) | 7 (1.1) | 1.0 |
Coronary perforation | 28 (3.0) | 10 (3.3) | 18 (2.9) | 0.838 |
Ellis type 2 or more | 18 (2.0) | 8 (2.7) | 10 (1.6) | 0.314 |
Requiring intervention | 12 (1.3) | 3 (1.0) | 9 (1.5) | 0.760 |
| ||||
Vascular complications | 30 (3.3) | 6 (2.0) | 24 (3.9) | 0.166 |
Retroperitoneal hematoma | 3 (0.3) | 1 (0.3) | 2 (0.3) | 1.0 |
Hematoma > 5 cm | 12 (1.3) | 5 (1.7) | 7 (1.1) | 0.542 |
Pseudoaneurysm | 12 (1.3) | 0 (0) | 12 (1.9) | 0.011 |
Acute limb ischemia | 3 (0.3) | 0 (0.5) | 3 (0.5) | 0.555 |
| ||||
Major vascular complication | 9 (1.0) | 3 (1.0) | 6 (1.0) | 1.0 |
| ||||
Others | ||||
Pericardial effusion | 16 (1.7) | 6 (2.0) | 10 (1.6) | 0.789 |
Major bleeding | 9 (1.0) | 3 (1.0) | 6 (1.0) | 1.0 |
Contrast-induced nephropathy | 16 (1.7) | 4 (1.3) | 12 (1.9) | 0.601 |
| ||||
Myocardial injury | ||||
hsTroponin T, baseline (ng/L) | 15 (9–30) | 18 (10–40) | 14 (9–25) | 0.003 |
hsTroponin T, day 1 (ng/L) | 43 (22–110) | 33 (18–90) | 50 (24–127) | <0.001 |
Coronary procedure-related myocardial injury | 462 (71.0) | 154 (61.1) | 308 (77.2) | <0.001 |
CTO, chronic total occlusion; hsTroponin T, high-sensitivity troponin T; MI, myocardial infarction. Troponin values are median with interquartile range. Dichotomous variables are reported as number (percentages). Significant p values below 0.05 are shown in bold.